Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Historical Acquisition Tree
Alternative names
Key: Heidelberg Pharma AG (0) Acquired (1)
girentuximab (5 trials)
Key: Heidelberg Pharma AG (1) Acquired (3)
felbamate (Felbatol) (2 trials)
gemcitabine (gemzar) (1 trial)
hdp-101 (1 trial)
upamostat (2 trials)
Key: Heidelberg Pharma AG (0) Acquired (3)
capecitabine (xeloda) (1 trial)
wx-037 (1 trial)
wx-uk1 (1 trial)
sunitinib (sutent) (1 trial)
Trials (11 total)
Trial APIs (9 total)